611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Health Tip: Help Prevent Bone FracturesLater-Life Fractures Up Risk of Early DeathAir Pollution at National Parks Keeps Visitors AwayIn the ICU, Patients' Relatives Often Mum About Care ConcernsHealth Tip: Prevent Bed Bugs at HomeHealth Tip: Treating Heat-Related IllnessU.S. Deaths From Liver Disease Rising RapidlySupplement May Ease the Pain of Sickle Cell DiseaseAHA: Vaping Tied to Blood Clots -- in MiceHealth Tip: Performing the Heimlich ManeuverThe Latest on Chronic Fatigue SyndromeAHA: Protect Your Heart and Health During 'Dog Days' of SummerHealth Tip: Care For an Incision After SurgeryAs Ticks Reach Record Numbers, Take PrecautionsObesity Adds to Burden of Traumatic Brain InjuryHidden Blood in Feces May Signal Deadly ConditionsFirst Drug to Treat Smallpox ApprovedVitamin D No Panacea for Brain DiseasesEczema Dramatically Impacts Quality of LifeTo Fend Off Migraines, Try Keeping a Headache DiaryAHA: Soccer Is Called the Beautiful Game, But Injuries Can Make It a Dangerous One100 Now Sickened by Salmonella-Tainted Honey Smacks CerealA 3-Pronged Plan to Cut Type 2 Diabetes RiskCan You Eat Your Way to Better Asthma Control?Are Concussions Tougher on Athletes With ADHD?Lyme-Bearing Ticks More Widespread in U.S. Than ThoughtHealth Tip: Shingles 101High Blood Pressure Threatens Aging Brain, Study SaysNeurological Fallout From Ebola Infection Worse Than ThoughtReport Warns of Dog Illness That Can Spread to OwnersHealth Tip: Caring for Your Epi-PenMore Evidence That Supplements Won't Help Your HeartHealth Tip: Asbestos Tips For HomeownersGerms Grow on Medical Implants, But Can They Make You Sick?FDA Drops Zika Testing for Blood Donors850 Million People Worldwide Have Kidney DiseaseAs Temperatures Soar, Study Warns of Fatal Heat Stroke at WorkFatigue Fuels Knee Injuries in Young AthletesWarming Climate, More AC -- and More Unhealthy Smog AheadHealth Tip: Understanding West Nile VirusCould Flea Fighters Stem Spread of Diseases Like Zika?Even Once-a-Week Pot Smokers Have More Cough, PhlegmZika Dangers During Pregnancy May Be Worse Than ThoughtHealth Tip: Use a Blood Thinner SafelyBeat the Heat on Your Summer VacationSitting Tied to Raised Risk of Death From 14 DiseasesCataract Surgery Tied to Fewer Car Crashes for Seniors'Walk & Think' Test Could Be Key to Concussion CareJuly Is Peak Time for Illness From Poop in Pools: CDCCould Estrogen Play a Role in Men's Migraines?
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

First Drug Approved for Rare Condition That Inflames Blood Vessels

HealthDay News
by -- Scott Roberts
Updated: Dec 12th 2017

TUESDAY, Dec. 12, 2017 (HealthDay News) -- Nucala (mepolizumab) has been approved by the U.S. Food and Drug Administration as the first remedy to treat adults with eosinophilic granulomatosis with polyangiitis, a rare autoimmune disease that leads to inflammation of the blood vessels.

Other symptoms of the condition, formerly called Churg-Stress syndrome, include asthma and an overabundance of an infection-fighting white blood cell called an eosinophil. The inflamed blood vessels may affect the lungs, intestines, skin, heart and nervous system.

The condition affects a total of about 11 out of every one million people in United States, the FDA said Tuesday in a news release.

"Patients taking Nucala in clinical trials reported a significant improvement in their symptoms," said Dr. Badrul Chowdhury, director of the FDA's Division of Pulmonary, Allergy and Rheumatology Products.

Nucala, a once-monthly injection, was first approved in 2015 to treat people 12 and older with a certain type of severe asthma, the FDA said. The drug's most common side effects include headache, injection-site reaction, back pain and fatigue.

People who are prone to a "hypersensitive" allergic reaction shouldn't take the drug, and those who are taking an inhaled corticosteroid medication to treat asthma should not abruptly stop the asthma remedy, the agency warned.

Nucala is produced by the British pharma firm GlaxoSmithKline, whose U.S. headquarters are in Warren, N.J.

More information

Visit the FDA to learn more.